Autonomic Dysregulation in Multiple Sclerosis
Citation
Pintér, Alexandra, Domonkos Cseh, Adrienn Sárközi, Ben M. Illigens, and Timo Siepmann. 2015. “Autonomic Dysregulation in Multiple Sclerosis.” International Journal of Molecular Sciences 16 (8): 16920-16952. doi:10.3390/ijms160816920. http://dx.doi.org/10.3390/ijms160816920.Abstract
Multiple sclerosis (MS) is a chronic, progressive central neurological disease characterized by inflammation and demyelination. In patients with MS, dysregulation of the autonomic nervous system may present with various clinical symptoms including sweating abnormalities, urinary dysfunction, orthostatic dysregulation, gastrointestinal symptoms, and sexual dysfunction. These autonomic disturbances reduce the quality of life of affected patients and constitute a clinical challenge to the physician due to variability of clinical presentation and inconsistent data on diagnosis and treatment. Early diagnosis and initiation of individualized interdisciplinary and multimodal strategies is beneficial in the management of autonomic dysfunction in MS. This review summarizes the current literature on the most prevalent aspects of autonomic dysfunction in MS and provides reference to underlying pathophysiological mechanisms as well as means of diagnosis and treatment.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581177/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:22856940
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)